Drug Database
Back to search

United States· US:62332-681_1b130bfa-78ff-40d2-8612-90e7133d2379

Albendazole

A albendazole product containing albendazole, registered in United States by Alembic Pharmaceuticals Inc.. The same ATC class is registered in 10 of our 19 countries.

ATC P02CA03US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedAlbendazoleATCP02CA03REGISTER NO.US:62332-681_1b130bfa…PACKS LISTED4CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about albendazoleAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Albendazole is registered in 10 of 19 countries.

Countries holding a registration under ATC P02CA03 (albendazole), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 6 of them publish a price we can compare per daily dose
Search albendazole products by name

Albendazole · ATC P02CA03

10 / 19 countries

  • Czechiaprice
  • Franceprice
  • Germany
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of albendazole costs, country by country.

Normalised to the WHO defined daily dose (0.8 g), the median price runs from $5.63 in France to $36.54 in Switzerland — a ×6.5 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Albendazole · price per daily dose (0.8 g)

USD · FX 28 Sept 2026

  • CH Switzerland$36.54
  • FR France$5.63
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
ALBENDAZOLE
Manufacturer
Alembic Pharmaceuticals Inc.
Country
United States (US)
ATC code
P02CA03
ATC class
Albendazole
Defined daily dose
0.8 g, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 4

  • ndc11
    62332-681-28
  • ndc11
    6233268102
    2 TABLET, FILM COATED in 1 BOTTLE (62332-681-02)
  • ndc11
    6233268128
    28 TABLET, FILM COATED in 1 BOTTLE (62332-681-28)
  • ndc11
    62332-681-02

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

114 interactions on record for albendazole.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check albendazole against other medicinesHow interaction checks work

Albendazole · interactions on record

114 records

  • 3 severe
  • 102 moderate
  • 9 minor

Most severe, free to view

  • CladribineL01BB04severe
  • CladribineL04AA40severe
  • ClozapineN05AH02severe
  • AprepitantA04AD12moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Albendazole in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All albendazole products

Authorised across Europe · EMA

The same active substance is authorised in 17 EEA countries. Names it is sold under:

  • Austria · Eskazole
  • Bulgaria · Зентел
  • Cyprus · Zestaval
  • Germany · Albendazol Micro Labs, Eskazole
  • Spain · Eskazole
  • France · Eskazole, Zentel
  • United Kingdom (Northern Ireland) · Albendazole Brown & Burk Uk
  • Greece · Albendol
  • Hungary · Albendazol Pharma Vim
  • Italy · Zentel
  • Luxembourg · Albendazol Micro Labs
  • Malta · Zestaval
  • Netherlands · Eskazole
  • Poland · Zentel
  • Portugal · Zentel
  • Romania · Albendazol Vim Spectrum, Duador
  • Slovakia · Zentel

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/70fa235d-9f69-40e2-a8f7-82fdcdaff494
GET /v1/drugs/70fa235d-9f69-40e2-a8f7-82fdcdaff494?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "200",
  "substance": "ALBENDAZOLE",
  "productndc": "62332-681",
  "dosage_form": "TABLET, FILM COATED",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA215652",
  "marketing_category": "ANDA"
}
API referenceMCP serverPlans

See everything about albendazole.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console